Vitae/Kevin Dye/Publications: Difference between revisions

From Future Worlds Center Wiki
Jump to navigationJump to search
Line 3: Line 3:
<ol type="1" start="1">
<ol type="1" start="1">


<li> 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID)
<li> 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID). Jones, P. H., & Dye, K. M. (2016). 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID). Dialogic Design International Dayton United States.
<li>
Jones, P. H., & Dye, K. M. (2016). 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID). Dialogic Design International Dayton United States.\


<li> Bacteriostatic polymer film immobilization. Journal of Biomedical Materials Research Part A, 79(4), 874-881.  El‐Hayek, R. F., Dye, K., & Warner, J. C. (2006).


<li> El‐Hayek, R. F., Dye, K., & Warner, J. C. (2006). Bacteriostatic polymer film immobilization. Journal of Biomedical Materials Research Part A, 79(4), 874-881.
<li> Developing Collaborative Leadership to Reframe the Safe Use of Pharmaceuticals as a National Health Priority. Final Report, CWA Ltd. Dye, K. M., Feudtner, C., Post, D., & Vogt, E. M. (1999).  


 
<li> Developing a Consensus on the Accountability and Responsibility for the Safe Use of Pharmaceuticals. Washington, DC: The National Patient Safety Foundation. Dye, K. M., Post, D., & Vogt, E. (1999).  
<li> Dye, K. M., Feudtner, C., Post, D., & Vogt, E. M. (1999). Developing Collaborative Leadership to Reframe the Safe Use of Pharmaceuticals as a National Health Priority. Final Report, CWA Ltd.
 
 
<li> Dye, K. M., Post, D., & Vogt, E. (1999). Developing a Consensus on the Accountability and Responsibility for the Safe Use of Pharmaceuticals. Washington, DC: The National Patient Safety Foundation.


<li> Environmental Impact Assessment Review. Krieg EJ, Faber DR, Steinemann A, Daughton CG, Montague P, Bailey D, Solomon G, Warner JC, Cannon AS, Dye KM, Tickner JA.  
<li> Environmental Impact Assessment Review. Krieg EJ, Faber DR, Steinemann A, Daughton CG, Montague P, Bailey D, Solomon G, Warner JC, Cannon AS, Dye KM, Tickner JA.  

Revision as of 03:18, 19 January 2022

Key Publications

  1. 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID). Jones, P. H., & Dye, K. M. (2016). 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID). Dialogic Design International Dayton United States.
  2. Bacteriostatic polymer film immobilization. Journal of Biomedical Materials Research Part A, 79(4), 874-881. El‐Hayek, R. F., Dye, K., & Warner, J. C. (2006).
  3. Developing Collaborative Leadership to Reframe the Safe Use of Pharmaceuticals as a National Health Priority. Final Report, CWA Ltd. Dye, K. M., Feudtner, C., Post, D., & Vogt, E. M. (1999).
  4. Developing a Consensus on the Accountability and Responsibility for the Safe Use of Pharmaceuticals. Washington, DC: The National Patient Safety Foundation. Dye, K. M., Post, D., & Vogt, E. (1999).
  5. Environmental Impact Assessment Review. Krieg EJ, Faber DR, Steinemann A, Daughton CG, Montague P, Bailey D, Solomon G, Warner JC, Cannon AS, Dye KM, Tickner JA.
  6. Democracy in Practice: Lessons from New England. Palihapitiya, M., & Dye, K. (2008).
  7. Application of the Structured Dialogic Design Process to Examining Economic Integration and Free Trade in Cyprus, Y. Laouris, T Taraszow, M Damdelen, I Dagli, D Beyatlı, A Karayiannis, K Dye, A Christakis, Action Learning and Action Research Journal, 21 (1) 11-52, 2015
  8. Co-laboratories of Democracy: Best Choices for Designing Sustainable Futures, Y Laouris, K Dye, M Michaelides, and AN Christakis, in: G.S. Metcalf (ed.), Social Systems and Design, Translational Systems Sciences 1, DOI 10.1007/978-4-431-54478-4_7, Springer Japan. 175-193, 2014
  9. Collaborative foresight: Complementing long-horizon strategic planning K Weigand, T Flanagan, K Dye, P Jones - Technological Forecasting and Social Change, 2013
  10. Democracy in Practice: Lessons from New England M Palihapitiya, K Dye - 2008
  11. The Cogniscope™ Lessons Learned in the Arena AN Christakis, K Dye - Dialogue as a Collective Means of Design …, 2008
  12. Photo-induced Copolymer Functionalized Substrates, J WARNER, A CANNON, K DYE - WO Patent 2,007,139,810, 2007
  13. Bacteriostatic polymer film immobilization RF El‐Hayek, K Dye, JC Warner - Journal of Biomedical Materials Research Part A, 2006, 79 (4), 874-881
  14. Research-Informed Models for Communicating the Value of Court-Connected Alternative Dispute Resolution for Public Funding K Dye - 2006
  15. Green chemistry JC Warner, AS Cannon, KM Dye - Environmental Impact Assessment Review, 2004, 24 (7), 775-799
  16. Collaboration through communicative action: Resolving the systems dilemma through the cogniscope AN Christakis, KM Dye - Systems: Journal of Transdisciplinary Systems …, 1999, 4 (1), 9-32
  17. Lessons Learned from Five Years of Application of the CogniScope™ Approach to the Food and Drug Administration KM Dye, DS Conaway - CWA Ltd. Report, 1999
Retrieved from "https://futureworlds.eu/wiki/index.php?title=Vitae/Kevin_Dye/Publications&oldid=25668"